UNSPSC 51113101: Defosfamide

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51113101

Definition

This classification denotes a nitrogen mustard compound with the molecular formula C9H20Cl3N2O3P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0W33021S30, chemically known as phosphorodiamidic acid, n,n-bis(2-chloroethyl)-n-(3-hydroxypropyl)-, (2-chloroethyl) ester but more generally known as defosfamide, which bears US NIH Compound Identifier 71164. European Medicines Agency schedules Defosfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06944MIG.

Read the full definition

The term DEFOSFAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). DEFOSFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule defosfamide under HS 29299000 and SITC 51489. As of Q4 2014, DEFOSFAMIDE remains US FDA's Preferred Term for this commodity. Defosfamide bears US NLM identifiers UMLS ID C1511757 and NCI Concept Code C2069. SMILES: CLCCN(P(=O)(OCCCL)NCCCO)CCCL.

About UNSPSC 51113101

UNSPSC 51113101 Defosfamide, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The one recent opportunity on record—Texas Health and Human Services Commission's Request for Information (RFI) HHS0017013, posted April 3, 2026—solicits vendor capabilities for a Therapeutic Pharmacy Initiative (TPI) Direct-to-Manufacturer Prescriptions program focused on pharmacy benefit management infrastructure, direct contracting models, and prescription fulfillment channels. This is a procurement strategy and vendor-qualification exercise, not a buy of the pharmaceutical product itself. The RFI seeks vendor experience with direct contracting, negotiated net pricing, value-based agreements, and volume fulfillment capacity across self-insured employer plans and government health programs, without specifying any purchase of defosfamide or other named drugs.

The code shows minimal relevant recent activity. Texas HHS is the sole identified issuing body in the current opportunity set, and the procurement mechanism—an RFI rather than a formal RFP, RFQ, IFB, or ITB—is exploratory only, with no award value, budget, or binding timeline disclosed. The state is gathering market intelligence to inform future pharmacy benefit procurement strategy rather than committing to specific pharmaceutical purchases or volumes. Defosfamide buyers considering this code should verify whether state and local health agencies are actually procuring the product under this UNSPSC designation or whether the tagging reflects a data classification mismatch.

Quick answers

What is UNSPSC 51113101?

UNSPSC 51113101 is Defosfamide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51113101?

UNSPSC 51113101 maps to 1 NIGP code, 26910 Antineoplastic Agents.

On GovTribe

See everything under UNSPSC 51113101

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code